NO20010513L - Nye 2,3,3a,4,9,9a heksahydro-8-hydroksy-1H-benz[f]indoler, en fremgangsmÕte for fremstilling derav og deres anvendelse som medikamenter - Google Patents

Nye 2,3,3a,4,9,9a heksahydro-8-hydroksy-1H-benz[f]indoler, en fremgangsmÕte for fremstilling derav og deres anvendelse som medikamenter

Info

Publication number
NO20010513L
NO20010513L NO20010513A NO20010513A NO20010513L NO 20010513 L NO20010513 L NO 20010513L NO 20010513 A NO20010513 A NO 20010513A NO 20010513 A NO20010513 A NO 20010513A NO 20010513 L NO20010513 L NO 20010513L
Authority
NO
Norway
Prior art keywords
benz
hexahydro
hydroxy
indoles
medicaments
Prior art date
Application number
NO20010513A
Other languages
English (en)
Other versions
NO20010513D0 (no
Inventor
Matthias Grauert
Christoph Hoenke
Adrian Carter
Wolf-Dietrich Bechtel
Thomas Weiser
Rainer Palluk
Uwe Pschorn
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20010513L publication Critical patent/NO20010513L/no
Publication of NO20010513D0 publication Critical patent/NO20010513D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010513A 1998-07-31 2001-01-30 Nye 2,3,3a,4,9,9a heksahydro-8-hydroksy-1H-benz[f]indoler, en fremgangsmåte for fremstilling derav og deres anvendelse som medikamenter NO20010513D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834714A DE19834714A1 (de) 1998-07-31 1998-07-31 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/005222 WO2000007986A1 (de) 1998-07-31 1999-07-22 Neue 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1h-benz[f]indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
NO20010513L true NO20010513L (no) 2001-01-30
NO20010513D0 NO20010513D0 (no) 2001-01-30

Family

ID=7876092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010513A NO20010513D0 (no) 1998-07-31 2001-01-30 Nye 2,3,3a,4,9,9a heksahydro-8-hydroksy-1H-benz[f]indoler, en fremgangsmåte for fremstilling derav og deres anvendelse som medikamenter

Country Status (29)

Country Link
US (1) US6051583A (no)
EP (1) EP1100780B1 (no)
JP (1) JP2002522418A (no)
KR (1) KR20010072142A (no)
CN (1) CN1147470C (no)
AT (1) ATE360611T1 (no)
AU (1) AU763834B2 (no)
BG (1) BG105178A (no)
BR (1) BR9912605A (no)
CA (1) CA2336783C (no)
CO (1) CO5080748A1 (no)
DE (2) DE19834714A1 (no)
EA (1) EA003370B1 (no)
EE (1) EE200100062A (no)
ES (1) ES2285851T3 (no)
HU (1) HUP0103518A3 (no)
ID (1) ID28292A (no)
IL (1) IL140863A0 (no)
MY (1) MY133085A (no)
NO (1) NO20010513D0 (no)
NZ (1) NZ510246A (no)
PL (1) PL345808A1 (no)
SK (1) SK1502001A3 (no)
TR (1) TR200100316T2 (no)
TW (1) TW464643B (no)
UA (1) UA68388C2 (no)
WO (1) WO2000007986A1 (no)
YU (1) YU5501A (no)
ZA (1) ZA200007770B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
JP2005514412A (ja) * 2001-12-27 2005-05-19 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 中枢神経系疾患を処置するために有用なアロイルピロールヘテロアリールおよびメタノール類

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648032B2 (en) * 1989-07-13 1994-04-14 Pharmacia & Upjohn Company (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives
AU2153592A (en) * 1991-05-20 1993-01-08 Upjohn Company, The Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
HUP0103518A2 (hu) 2002-01-28
HK1038017A1 (en) 2002-03-01
EE200100062A (et) 2002-06-17
CN1310707A (zh) 2001-08-29
PL345808A1 (en) 2002-01-02
KR20010072142A (ko) 2001-07-31
BG105178A (bg) 2001-12-29
ID28292A (id) 2001-05-10
EP1100780A1 (de) 2001-05-23
TW464643B (en) 2001-11-21
BR9912605A (pt) 2001-05-02
CA2336783A1 (en) 2000-02-17
DE19834714A1 (de) 2000-02-03
CN1147470C (zh) 2004-04-28
ATE360611T1 (de) 2007-05-15
US6051583A (en) 2000-04-18
AU5162699A (en) 2000-02-28
JP2002522418A (ja) 2002-07-23
ES2285851T3 (es) 2007-11-16
TR200100316T2 (tr) 2001-07-23
EP1100780B1 (de) 2007-04-25
IL140863A0 (en) 2002-02-10
UA68388C2 (en) 2004-08-16
AU763834B2 (en) 2003-07-31
YU5501A (sh) 2003-04-30
NZ510246A (en) 2003-08-29
DE59914314D1 (de) 2007-06-06
SK1502001A3 (en) 2001-09-11
EA003370B1 (ru) 2003-04-24
EA200100107A1 (ru) 2001-08-27
CA2336783C (en) 2009-04-28
MY133085A (en) 2007-10-31
HUP0103518A3 (en) 2002-12-28
CO5080748A1 (es) 2001-09-25
WO2000007986A1 (de) 2000-02-17
ZA200007770B (en) 2002-01-17
NO20010513D0 (no) 2001-01-30

Similar Documents

Publication Publication Date Title
WO2001046200A8 (en) Novel piperidine and piperazine derivatives
SE9904505D0 (sv) Novel compounds
NO20011478D0 (no) Nye N-(iminometyl)aminderivater, fremgangsmÕte for fremstilling derav, anvendelse som medikamenter og sammensetninger inneholdende dem
BG101250A (en) Salts of an anti-migraine indole derivative
BR0311593A (pt) Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO20054787L (no) Indenderivater som farmasotiske midler
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
IL140863A0 (en) Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz [f] indoles, a method for the production thereof and their use as medicaments
DK1000067T3 (da) Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne
NO20000199L (no) Medikamenter inneholdende polyhydroksybutylpyraziner, nye polyhydroksybutylpyraziner og deres fremstilling
HUP0104213A2 (hu) Vankoreszmicin, eljárás előállítására és gyógyszerként történő alkalmazása
GEP20084296B (en) Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
SE9803107D0 (sv) Novel Compunds
CA2287991A1 (en) New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
BG104964A (bg) Подобрен метод за получаване на фармацевтично ценни норбензоморфанови производни

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application